Medicover took over the Nasz Doctor center providing medical services and clinical trials




Medicover took over the Nasz Doctor center providing medical services and clinical trialsWarsaw, 04/07/2022 (ISBnews) – Medicover has finalized the acquisition of the Nasz Doctor facility, which provides medical services and clinical trials, the company said. It is one of the main centers of this type in Poland. This is a joint transaction between the two Medicover divisions – Diagnostic Services and Healthcare Services – because Medicover has also signed an agreement to acquire a local clinic under the name Our Doctor. The transaction includes a modern property with an area of ​​2,000 m2. “Our doctor clinics have been operating in Toruń and Bydgoszcz for 20 years, providing services to approx. 15 thousand. patients. A team of over 100 doctors and nurses provides medical care as part of primary health care and specialist outpatient care through 36 clinics and 20 laboratories. The wide range of services provided includes: occupational medicine, sports medicine, travel medicine and clinical trials. The investment will allow the Healthcare Services division to mark a strong Medicover presence in the province. kujawsko-pomorskie “- we read in the release. Our Doctor is a synergistic investment for both Medicover divisions. Diagnostic Services will use the potential of the clinic team, which will enable growth in the strategic areas of research management and including patients in clinical trials, while the Healthcare Services division, Medicover, will strengthen high-quality medical care on the Polish medical services market. The Toruń clinic is an attractive supplement to the Healthcare Services activity, providing patients with multi-specialist care and responding to the growing demand for quality care in this region, it was also emphasized. “The acquisition of the Our Doctor business is key to Medicover’s strategy to develop Diagnostic Services in the area of ​​clinical trials. This is the perfect time to strengthen our global presence in the life science industry, using the potential of the acquired entity, its experience and regional infrastructure corresponding to the services of clinical laboratories, patient management and accompanying diagnostics. We are one step closer to becoming a comprehensive partner for life science companies and clinical research organizations, supporting them in introducing innovative therapies and diagnostics to the market, ”said Staffan Ternström, COO Diagnostic Services, quoted in the release. The acquisition of the clinical trials business area Our Doctor allows Medicover Integrated Clinical Services (MICS) to further synergistic cooperation with global partners from the pharmaceutical industry and to strengthen the already developed activity in the field of clinical laboratory services, patient management and accompanying diagnostics. MICS is a specialized business unit within the Diagnostic Services division with the ambition to become a strong global player and accelerate the integration of innovative diagnostics and therapy within Medicover, summarized. Medicover provides a wide range of healthcare services, including outpatient and specialist care, a network of hospitals, laboratories and blood collection points provided within two divisions – Healthcare Services and Diagnostic Services. (SIBnews) See other phrases most searched for today: pound rate forecast 2021 | biomed-lublin gpw | stock market recommendations | pekao course | selvita shares recommendations | pound nbp rate | develia gpw |
XTB

Follow us on Google News. Search for what’s important and stay up to date with the market! Watch us >>